Susquehanna International Group’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$247K Buy
36,815
+4,855
+15% +$32.6K ﹤0.01% 5290
2025
Q1
$289K Buy
31,960
+19,028
+147% +$172K ﹤0.01% 5062
2024
Q4
$224K Buy
+12,932
New +$224K ﹤0.01% 5151
2024
Q3
Hold
0
6555
2023
Q2
Sell
-196,513
Closed -$2.85M 6463
2023
Q1
$2.85M Buy
196,513
+84,716
+76% +$1.23M ﹤0.01% 1586
2022
Q4
$1.51M Buy
+111,797
New +$1.51M ﹤0.01% 1865